Evaluating ZNF217 mRNA Expression Levels as a Predictor of Response to Endocrine Therapy in ER+ Breast Cancer

ZNF217 is a candidate oncogene with a wide variety of deleterious functions in breast cancer. Here, we aimed at investigating in a pilot prospective study the association between ZNF217 mRNA expression levels and the clinical response to neoadjuvant endocrine therapy (ET) in postmenopausal ER-positi...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Front Pharmacol
Main Authors: Vendrell, Julie A., Solassol, Jérôme, Győrffy, Balázs, Vilquin, Paul, Jarlier, Marta, Donini, Caterina F., Gamba, Laurent, Maudelonde, Thierry, Rouanet, Philippe, Cohen, Pascale A.
Format: Artigo
Sprog:Inglês
Udgivet: Frontiers Media S.A. 2019
Fag:
Pharmacology
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6355665/
https://ncbi.nlm.nih.gov/pubmed/30740056
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2018.01581
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker